CoChat

Influence of the Carbohydrate Moieties on the Immunoreactivity and Digestibility of the Egg Allergen Ovomucoid

Open access
Benedé, Sara, López-Fandiño, Rosina, Reche, Marta, Molina, Elena, López-Expósito, Iván · 2013 · PLoS ONE

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 2 of the 13 sources its claims cite were checked for support.

Abstract

BACKGROUND: Ovomucoid (OM) has two carbohydrate chains on each of the first and second domains and one in the third. The contribution of the covalently bound carbohydrate chains to the overall OM allergenicity is controversial. Another aspect directly related with the immunological properties of OM that has not been studied in depth is the importance of the carbohydrate chains on its digestibility. OBJECTIVE: The aim of the study was to assess the involvement of the carbohydrate moieties of OM in its digestibility and allergenic properties. METHODS: IgE-binding and basophil activation by glycosylated and enzymatically deglycosylated OM (dOM) were compared using blood from egg-allergic patients. The peptides obtained after digestion using a physiologically relevant model were identified by RP-HPLC-MS/MS and the IgE-binding of the resulting fragments was evaluated by DOT-Blot. RESULTS: No structural changes were observed after deglycosylation of OM. 80% of the patients showed lower IgE binding to dOM as compared with OM and, in some patients, IgE reactivity could not be inhibited by pre-incubation with dOM. A subtle reduction in the percentage of activated basophils was observed when incubated with dOM as compared to OM. Following simulated digestion, dOM was more extensively degraded than OM, particularly during the gastric phase and both, OM and dOM, yielded, after the duodenal phase, immunoreactive fragments that were totally or partially coincident with previously described epitopes. CONCLUSION & CLINICAL RELEVANCE: this work demonstrated an enhanced IgE reactivity towards carbohydrate containing OM in some egg-allergic patients that could be attributed to cross-sensitization or sensitization to the glycosylated components. The carbohydrate chains contributed to an increased resistance to proteolysis, and thus, to its allergenic potency. Evaluation of the products of digestion of OM and dOM revealed the presence of high-frequency IgE-binding epitopes that could remain linked by disulphide bonds.

Overview

CoChat Summary

## TL;DR

This study tested whether ovomucoid’s carbohydrate moieties affect its allergenicity and digestibility using sera and cells from egg-allergic patients plus simulated digestion. Removing glycans did not change ovomucoid’s overall structure, but it reduced IgE binding in most patients and made the protein more susceptible to gastric proteolysis.

## Key findings

  • After enzymatic deglycosylation, 80% of patients showed lower IgE binding to dOM than to native OM.
  • In Western blot inhibition, some patients’ IgE reactivity to OM could not be fully inhibited by dOM, suggesting IgE recognition of glycosylated structures in some cases.
  • Basophil activation was subtly reduced with dOM compared with OM, but the difference was not statistically significant.
  • During simulated digestion, dOM was more extensively degraded than OM, especially in the gastric phase; after gastric digestion, OM yielded fragments of ~25, ~15, and <10 kDa, while dOM yielded mainly ~18, ~15, and <10 kDa bands.
  • IgE-binding of digestion products fell to ~10.6% for OM and 1.2% for dOM after the gastric phase, and to 4.16% and 1.1%, respectively, after the duodenal phase.
  • RP-HPLC-MS/MS identified 146 peptides from digests, with 56 peptides in common between OM and dOM; the authors report high-frequency IgE-binding regions at residues 80–89 and 133–180.

## Methods

  • Design: Experimental comparison of glycosylated OM vs enzymatically deglycosylated OM (dOM), including structural analysis, patient IgE assays, basophil activation, and simulated oral-gastric-duodenal digestion.
  • Samples/data: Serum from egg-allergic patients (patients 1–16 in different assays) and PBMCs from 6 egg-tolerant adult donors that were re-sensitized with pooled patient sera.
  • Main analysis: SDS-PAGE and PAS staining, circular dichroism, inhibition ELISA, Western blot/inhibition Western blot, basophil activation by flow cytometry, simulated digestion, RP-HPLC-MS/MS peptide identification, and DOT-blot IgE testing of 17 synthesized peptides.

## Limitations

  • The paper states that only non-glycosylated fragments were identified by RP-HPLC-MS/MS because glycopeptide detection in complex mixtures is difficult.
  • The paper notes that clinical relevance remains to be established for the direct effect of OM carbohydrate chains on IgE binding.
  • Evident from the text: the work uses in vitro digestion and ex vivo assays, so it does not directly measure clinical reactions in patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0080810

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 OM deglycosilation results. SDS-PAGE patterns of OM and its deglycosylated form (dOM) with Coomassie blue (a) or PAS (b) staining M: molecular mass marker; 1: OM, 2: dOM. Circular dichroism spectra in the far (c) and near (d) UV region of OM (−) and dOM (---). The spectra were recorded in phosphate buffer, pH 7.0, at 20°C.
Figure 1 OM deglycosilation results. SDS-PAGE patterns of OM and its deglycosylated form (dOM) with Coomassie blue (a) or PAS (b) staining M: molecular mass marker; 1: OM, 2: dOM. Circular dichroism spectra in the far (c) and near (d) UV region of OM (−) and dOM (---). The spectra were recorded in phosphate buffer, pH 7.0, at 20°C.CC BY · PubMed Central
Figure 2 OM and dOM immunoreactivity . Binding to human IgE, using sera from 10 egg-allergic individuals (patients 1-10, Table 1), of OM (gray) and dOM (black), expressed as EC50, or effective OM or dOM concentration (μg/mL) to inhibit 50% of the IgE binding to OM (a). SDS-PAGE (b) and Western blot analyses (c-l) of OM (1) and dOM (2) with sera from the same 10 individuals (1-10, respectively, used in the ELISA). Human sera were either no incubated (A) or previously incubated (B) with the amount of dOM calculated to inhibit 100 % of IgE binding.
Figure 2 OM and dOM immunoreactivity . Binding to human IgE, using sera from 10 egg-allergic individuals (patients 1-10, Table 1), of OM (gray) and dOM (black), expressed as EC50, or effective OM or dOM concentration (μg/mL) to inhibit 50% of the IgE binding to OM (a). SDS-PAGE (b) and Western blot analyses (c-l) of OM (1) and dOM (2) with sera from the same 10 individuals (1-10, respectively, used in the ELISA). Human sera were either no incubated (A) or previously incubated (B) with the amount of dOM calculated to inhibit 100 % of IgE binding.CC BY · PubMed Central
Figure 3 Basophil activation assays. Percentage of activated basophils (CD63+CD123+CD203c+HLA-DRlow) after stimulation with OM and dOM at concentrations between 10 to 0.01 μg/mL. PBMCs from 6 egg-tolerant adult donors were passively sensitized with a pool of sera from 5 children with egg allergy (patients 1, 3, 5, 7 and 9, Table 1). Bars indicate the mean of activated basophils.
Figure 3 Basophil activation assays. Percentage of activated basophils (CD63+CD123+CD203c+HLA-DRlow) after stimulation with OM and dOM at concentrations between 10 to 0.01 μg/mL. PBMCs from 6 egg-tolerant adult donors were passively sensitized with a pool of sera from 5 children with egg allergy (patients 1, 3, 5, 7 and 9, Table 1). Bars indicate the mean of activated basophils.CC BY · PubMed Central
Figure 4 Orogastrointestinal digestions profile and immunoreactivity. SDS-PAGE patterns (a, b) and Western blotting (c, d) of OM (a, c) and dOM (b, d) after in vitro oral, gastric and gastroduodenal digestions. M: molecular mass marker; 1: OM (a, c) and dOM (b, d); 2: oral digest; 3-13: gastric digests at 1, 2, 3, 4, 5, 7, 10, 15, 20, 30 and 60-min; 14: duodenal digests (60 min of gastric digestion followed by 30 min of duodenal digestion). Membranes were incubated with a pool of sera (patients 1, 3, 5, 7 and 9, Table 1).
Figure 4 Orogastrointestinal digestions profile and immunoreactivity. SDS-PAGE patterns (a, b) and Western blotting (c, d) of OM (a, c) and dOM (b, d) after in vitro oral, gastric and gastroduodenal digestions. M: molecular mass marker; 1: OM (a, c) and dOM (b, d); 2: oral digest; 3-13: gastric digests at 1, 2, 3, 4, 5, 7, 10, 15, 20, 30 and 60-min; 14: duodenal digests (60 min of gastric digestion followed by 30 min of duodenal digestion). Membranes were incubated with a pool of sera (patients 1, 3, 5, 7 and 9, Table 1).CC BY · PubMed Central
Figure 5 Peptide identification and IgE binding properties. Peptide sequences, identified by RP-HPLC-MS/MS, in the gastric (60 min) and subsequent duodenal digests of OM and dOM (60 min of gastric followed by 30 min of duodenal digestion), and IgE binding, estimated by immunodot with 10 sera of egg-allergic patients (patients 1-10, Table 1), of 17 synthetic peptides selected within the peptides identified in the simulated digestions.
Figure 5 Peptide identification and IgE binding properties. Peptide sequences, identified by RP-HPLC-MS/MS, in the gastric (60 min) and subsequent duodenal digests of OM and dOM (60 min of gastric followed by 30 min of duodenal digestion), and IgE binding, estimated by immunodot with 10 sera of egg-allergic patients (patients 1-10, Table 1), of 17 synthetic peptides selected within the peptides identified in the simulated digestions.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 6 Not checked · 25 Own results and interpretations

13 more claims

Create a free account to see all 33 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 14

Create a free account to see these claims.

Citations

Cites

Show all 33 references

Cited by

See all 33

Metadata

Authors
Benedé, S., López-Fandiño, R., Reche, M., Molina, E., & López-Expósito, I.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Hospital Universitario Infanta Sofía (ES)
Venue
PLoS ONE
Published
2013-11-14
Volume
8
Issue
11
Pages
e80810
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2015982412
Cited by
33
References
33
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 2
FWCI
2.26
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministerio de Economía y Competitividad
  • CYTED Ciencia y Tecnología para el Desarrollo (IBEROFUN 110AC0386)
  • Consejo Superior de Investigaciones Científicas
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
ovomucoid, egg allergy, carbohydrate moiety, glycosylation, allergenicity, IgE binding, basophil activation, protease resistance, in vitro digestion, IgE epitopes, cross-sensitization, deglycosylation, disulfide bonds
MeSH terms
Allergens, Eggs, Humans, Immunoglobulin E, Ovomucin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of the Carbohydrate Moieties on the Immunoreactivity and Digestibility of the Egg Allergen Ovomucoid. https://app.cochat.ai/papers/10.1371/journal.pone.0080810
The paper
Benedé, S., López-Fandiño, R., Reche, M., Molina, E., & López-Expósito, I. (2013). Influence of the Carbohydrate Moieties on the Immunoreactivity and Digestibility of the Egg Allergen Ovomucoid. PLoS ONE. https://doi.org/10.1371/journal.pone.0080810

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.